Old Web
English
Sign In
Acemap
>
authorDetail
>
Edward R. Hammond
Edward R. Hammond
AstraZeneca
Medicine
Internal medicine
disease severity
Cohort study
Health care
7
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004-2015.
2021
Lupus science & medicine
Miao Jiang
Aimee Near
Barnabas Desta
Xia Wang
Edward R. Hammond
Show All
Source
Cite
Save
Citations (0)
Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004-2015.
2021
Lupus science & medicine
Edward R. Hammond
Barnabas Desta
Aimee Near
Xia Wang
Miao Jiang
Show All
Source
Cite
Save
Citations (0)
The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization.
2021
Andreas Schwarting
Heiko Friedel
Elena Garal-Pantaler
Marc Pignot
Xia Wang
Henk Nab
Barnabas Desta
Edward R. Hammond
Show All
Source
Cite
Save
Citations (4)
OP0128 SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE CHARACTERISTICS ASSOCIATED WITH THE TYPE I INTERFERON GENE SIGNATURE: BASELINE DATA OF THE SLE PROSPECTIVE OBSERVATIONAL COHORT STUDY (SPOCS)
2019
Annals of the Rheumatic Diseases
Edward R. Hammond
Martin Aringer
Laurent Arnaud
Christine A. Peschken
Jacob Knagenhjelm
Volkan Barut
Xia Wang
Barnabas Desta
Raj Tummala
David Ginkel
Richard Furie
Eric F. Morand
Show All
Source
Cite
Save
Citations (0)
Perspectives on Safety and Efficacy—The BOLD Phase 2 Extension Study of Siponimod in Relapsing-Remitting Multiple Sclerosis
2016
JAMA Neurology
Edward R. Hammond
Show All
Source
Cite
Save
Citations (4)
1